Applications are invited for potential entrepreneurs, who have the backing of a host institution, to commercialise the outcomes of their STFC funded research. The closing date is 16th May 2014.
Funded by STFC and delivered by the Royal Society of Edinburgh, this one year Enterprise Fellowship is designed to give the fellow both the time to develop the commercialisation idea and the training to develop their business skills. Fellows will be paired with a mentor giving them a valuable insight and connection to the business world. The aim of the scheme is to make both the technology and the fellow more competitive in business.
Applications will need to show that there is an STFC technology that has commercial potential and that the prospective fellow has the commitment to develop and utilise their business skills. Previous fellowships include using software that was initially designed to help control spacecraft systems, developed into revolutionary animation software leading to the spin out IKinema, work on hydrogen storage that lead to the spin out Cella Energy and imaging technologies, which supported the spin out Symetrica.
For further information and application forms please follow the relevant links to the RSE and STFC and for any questions please contact Anne Fraser at the RSE email@example.com or Phillip Tait at STFC firstname.lastname@example.org
Dr Curtis Dobson has won the Commercial Innovator of the Year award at the BBSRC’s Fostering Innovation Awards 2014. The awards were presented at a high-profile event in London on 20 March 2014 in front of an invited audience of leading figures from the worlds of investment, industry, government, charity and academia.
He scooped the £15,000 award is recognition of the successful transfer of technology and resultant healthcare impact over many years with two University of Manchester spin-out companies based on Dr Dobson’s research: Ai2 Ltd and Microsensor Ltd.
Ai2 Ltd has developed anti-infective peptide technology for use in ophthalmics and in medical devices, such as urinary catheters and stents as well being utilised in wound dressings and consumer products.
Microsensor Ltd is developing a new approach to the early detection of medical device infection and environmental monitoring The technology is simple, inexpensive and robust, providing a clear ‘yes/no’ signal, indicating a clinically or industrially relevant level of infection on a surface, thereby enabling early intervention.
Dr Curtis Dobson said: “Being recognised by this BBSRC award is a privilege and an honour, and further validates our efforts to tackle resistant infection, which impacts so many people throughout the UK and beyond. The additional funds will help us accelerate commercialisation of our latest technologies, ultimately delivering benefits to patients sooner.”
Professor Ian Kimber, FLS’s Associate Dean for Business Development comments: “This is a remarkable achievement and is a testament to the industry and innovation of Curtis and his co-workers. It is a reflection also of the emphasis we place on ensuring that the fruits of our substantial investment in research deliver valuable products and opportunities.”
Clinical challenge: Reducing harm and enhancing safety across Greater Manchester and beyond.
Background: The Greater Manchester Academic Health Science Centre Network (GMAHSN), Manchester: Integrating Medicine and Innovative Technology (MIMIT) and TRUSTECH are working together to address unmet healthcare needs in the area of ‘reducing harm and enhancing safety across Greater Manchester and beyond.’ We are now seeking any potential device that will address these broad challenges.
Scope: Any device that addresses the clinical challenge.
We are particularly interested and priority will be given to devices that:
- Facilitate medicines risk surveillance, alert and /or response in primary care.
- Monitor and prevent falls
- Monitor and prevent leg ulcers
- Facilitate cardiac and renal disease risk surveillance, alert and /or response in primary care.
This specific call does not include technologies for data mining / handling big data.
Objective: To provide 8 months seed grant funding to support early stage technology innovation that will: 1) accelerate the development of new healthcare technologies to the point where they can lever further investment, 2) facilitate early collaboration with industry and 3) ultimately enable them to benefit patient care faster and more effectively.
Amount of award per project: Up to £40k total per project will be awarded for a period of up to 8 months.
Eligibility: This initiative is open to investigators employed by any of the GMAHSN organisations and / or Greater Manchester SMEs
Application process: All applications must be submitted through the MIMIT CoLab web based platform.
Click the following link to login: https://mimitcolab.induct.no/login
Applications are evaluated in two phases: a solicitation for two-page Outline Proposal and a second phase for Full Research Proposals. Outline Proposals are structured to enable you to briefly describe:
– The clinical need that the technology is addressing
– The technology / idea
– How the technology will address the unmet healthcare need?
– Which of the specific aspects of the clinical problem you are addressing?
– The expertise within the team to address the unmet healthcare need.
If invited to the full proposal stage you will be required to provide in seven pages:
– Clinical unmet need addressed, including details of the magnitude of Clinical problem (Incidence, medical impact, cost of the problem, underlying trends).
– A summary of the proposed work
– A description of the proposed solution and why it should be pursued
– A description of the proposed work, specific aims and associated milestones
– A description of the team members and their contributions
– An outline of the potential challenges and how they may be addressed
– How you will manage any potential IP arising from the project
– A breakdown of the budget and associated justification
– An outline of the next steps you anticipate upon completion of the proposed work
Deadline for submission of outline proposals is midnight on the 5th May 2014
Based upon a review and selection of the most promising projects in phase one, invitations are extended to a limited number of applicants to submit full proposals during phase two. The deadline for submission for full proposals will be midnight on the 31st May 2014.
Successful proposals will demonstrate:
- The potential impact of the device on patient care
- The technology is likely to lead to longer term clinical adoption
- The proposal fits logically into a technology development plan
- A clear project plan and pathway for development
- Opportunity for industry collaboration or early industry engagement where appropriate
- The proposal is a maximum of 8 months duration and can be delivered February 28, 2015.
Likelihood of leading to follow on funding.
The CryoMan-SMR™ team will be heading to the Gastech 14 conference and exhibition in Seoul, South Korea this week to promote its innovative and efficient gas liquefaction process.
Professionals, companies and various other interested parties within the natural gas and liquefied natural gas (LNG) industries flock to the event, which takes place every 18 months and which features a robust programme of papers and technical seminars.
The CryoMan-SMR™ consortium’s Simon Clarke from UMIP, The University of Manchester’s agent for Intellectual Property commercialisation, will be attending the four-day event, which runs from Monday March 24th to Thursday 27th.
“The Gastech Conference offers a great opportunity for CryoMan-SMR™, enabling us to present our process and technology to members of the entire LNG supply chain.”
“The 2012 London event was fantastic for the consortium, which managed to ignite the interest of a number of leading companies. One of these is currently carrying out an assessment of our proprietary process.”
“CryoMan-SMR™ is ideally placed to service an industry where increases in efficiency are so highly sought-after. Companies in the sector expend a great deal of time and effort on achieving modest improvements, so it’s no surprise that there’s such a great deal of interest in our approach – which can deliver significant productivity gains whilst retaining simplicity of design and construction. In many cases, it may be possible to retrofit CryoMan-SMR™ on to existing plant,” he said.
The Gastech Exhibition serves some of the industry’s most valuable decision-makers and buyers, providing an invaluable hub for organisations and individuals interested in networking and building strategic partnerships.
Similarly, its conference programme will see leading delegates from across the globe come together to discuss important industry issues, including the growing demand for gas and LNG in Asia, significant new commercial and technical opportunities, as well as a wealth of ground-breaking new project presentations.
Would you benefit from being able to discuss your challenges with an impartial industry insider and develop your own knowledge and skills? Or would others benefit from your wealth of experience?
The Greater Manchester Business Growth Hub is working in partnership with Bionow and other biomedical industry partners to offer access to industry insiders with expertise to help ambitious business people to achieve their growth ambitions.
Aimed at SMEs based in the North of England we are bringing together mentees and mentors through 1-2-1 professional mentoring relationships, which will offer fresh insight for innovative Biomedical businesses developing their management and leadership capabilities, hone their strategies and ultimately achieve business growth in this demanding sector.
Mentors will share their experience and expertise to enhance the mentees’ skills and knowledge, identifying relevant areas for development and providing an invaluable professional relationship.
Why not find out more by coming along to meet likeminded people at our launch event at Manchester Science park or attend one of our exclusive mentoring workshops. Numbers are limited so give us a call on 0161 359 3050 or email us at email@example.com
The reason the Government is funding this programme is because all the evidence shows that companies who receive external advice are more likely to grow and according to research, on average they grow 50% more than SME’s who do not.
The Launch of the fully funded Mentoring meets Biomed programme, is taking place at Manchester Science Park this Thursday at 5pm, followed by the three induction dates. If you cannot make the Launch, please book straight onto one of the Induction events.
Here are the links to each of the events:
Launch on Thursday 13th March at 5pm
Induction on Tuesday 18th March at Daresbury.
Induction on Thursday 20th March at Manchester
Induction on Tuesday 25th at Liverpool.
You can Book a Place on each of the events pages, and if you are not already signed up to the Business Growth Hub, you can do it there and then, as you have to in order to go to any event.